Manchester Capital Management LLC purchased a new position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 1,000 shares of the company’s stock, valued at approximately $63,000. Several other hedge funds and other institutional investors have also […]

Related Keywords

California , United States , Canada , Manchester , United Kingdom , Raju Prasad , Samarth Kulkarni , Barclays , Brown Advisory Inc , Legacy Capital Group California Inc , Securities Exchange Commission , Citigroup , Sheaff Brock Investment Advisors , Manchester Capital Management , Farrow Financial Inc , Beacon Pointe Advisors , Royal Bank , Free Report , Brock Investment Advisors , Pointe Advisors , Capital Group California , Farrow Financial , Get Free Report , Exchange Commission ,